Riskpilot← Back to searchSign inGet full accessSALBERG FYSIOTERAPI AS
ASActiveOrg 926594311Prestaskjersveien 30, 4058 TanangerPhysiotherapy activities · NACE 8695Est. 20211 employees
Revenue 2025
NOK 1,2M
-21% vs 2024
EBITDA margin
24.4%
+101% vs 2024
Equity ratio
68.4%
Financial strength
Net profit 2025
NOK 234K
+88% vs 2024
| Revenue | NOK 1,2M | -21% |
| EBITDA | NOK 288K | +101% |
| Net profit | NOK 234K | +88% |
| Total assets | NOK 654K | +57% |
| Equity | NOK 447K | +110% |
| Employees | 1 | — |
Legal name
SALBERG FYSIOTERAPI AS
Org number
926594311
Legal form
Aksjeselskap
NACE code
8695 · Physiotherapy activities
Founded
15. februar 2021
Share capital
NOK 30 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Gi fysioterapibehandling og annet som naturlig faller sammen med dette, herunder å delta i andre selskap med lignende virksomhet, og kjøp og salg av aksjer eller på annen måte gjøre seg interessert i andre foretak.
Address
Prestaskjersveien 30, 4058 Tananger
Phone
+4773545435
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 452 | 1 282 | 1 497 | 1 488 | 1 179 |
| Staff expenses | −1 153 | −979 | −1 019 | −888 | −487 |
| EBITDA | −7 | −25 | 60 | 143 | 288 |
| Depreciation & amort. | −6 | −6 | −0 | −0 | −0 |
| EBIT | −13 | −31 | 60 | 143 | 288 |
| Net financials | 0 | −6 | 13 | 13 | 10 |
| Profit before tax | −13 | −36 | 72 | 156 | 298 |
| Tax | −4 | −8 | 15 | 31 | 63 |
| Net profit | −9 | −28 | 57 | 125 | 234 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 355 | 230 | 344 | 417 | 654 |
| Equity | 59 | 31 | 88 | 213 | 447 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 296 | 199 | 256 | 204 | 207 |
| Total debt | 296 | 199 | 256 | 204 | 207 |
EBITDA margin
24.4%
This company
15.8%
Market median
+54% vs market
20212025
Equity ratio
68.4%
This company
38.2%
Market median
+79% vs market
20212025
Return on equity
52.4%
This company
18.4%
Market median
+185% vs market
20212025
Net profit margin
19.9%
This company
8.1%
Market median
+146% vs market
20212025
Asset turnover
1.80×
This company
1.12×
Market median
+61% vs market
20212025
Debt / equity
0.46×
This company
0.62×
Market median
+26% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-02-02 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
BS Chief Executive Officer | Chief Executive Officer | 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of SALBERG FYSIOTERAPI AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Bodil Salberg | Chief Executive Officer | 0 companies |
| Bettina Lindgren | Board of Directors | 0 companies |